Equine CysC antibody and antigen (recombinant protein)

Diagnostic anti-Equine CysC antibodies pairs and antigen for animal health (animal Equine/Horse Hormone disorders) testing in ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA and POCT

Target products collectionGo to Equine disease testing products collection >>


Product information

Catalog No.DescriptionUS $ Price (per mg)
GMP-EQU-CysC-Ag01Equine CysC$3090.00
GMP-EQU-CysC-Ab01Anti-Equine CysC mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CysC-Ab02Anti-Equine CysC mouse monoclonal antibody (mAb)$3090.00
GMP-EQU-CysC-Ab03Anti-Equine CysC human monoclonal antibody (mAb)$3090.00
GMP-EQU-CysC-Ab04Anti-Equine CysC human monoclonal antibody (mAb)$3090.00

Size： 1mg | 10mg | 100mg



Product Description

Cat No. GMP-EQU-CysC-Ag01
Product NameEquine CysC
Target/BiomarkerEquine CysC
Expression platformE.coli
IsotypesRecombinant Antigen
Bioactivity validationAnti-Equine CysC antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in cystatin C (CysC) level test of animal Equine/Horse with Hormone disorders.
TagHis
Reconized/Reactive SpecicsEquine CysC
Product descriptionRecombinant Equine CysC protein was expressed in E.coli - based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CysC-Ab01,GMP-EQU-CysC-Ab02
Target/BiomarkerEquine CysC
Product NameAnti-Equine CysC mouse monoclonal antibody (mAb)
Expression platformCHO
Isotypes Mouse IgG
Bioactivity validationRecombinant Equine CysC antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CysC antibodies in Equine CysC level test of animal Equine/Horse with Hormone disorders.
Product descriptionAnti-Equine CysC mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by CHO technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CysC antibodies.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Cat No.GMP-EQU-CysC-Ab03,GMP-EQU-CysC-Ab04
Target/BiomarkerEquine CysC
Product NameAnti-Equine CysC human monoclonal antibody (mAb)
Expression platformCHO
IsotypesHuman lgG1
Bioactivity validationRecombinant Equine CysC antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other anti-Equine CysC antibodies in Equine CysC level test of animal Equine/Horse with Hormone disorders.
Product descriptionAnti-Equine CysC mouse monoclonal antibody (mAb) is a human monoclonal antibody produced by CHO. The antibody is ELISA validated as capture antibody and detection antibody pair.
PurityPurity: ≥95% (SDS-PAGE)
Application Paired antibody immunoassay validation in sandwich Elisa, ELISA, colloidal gold-based Lateral flow immunoassay (LFIA), CLIA, TINIA, POCT and other immunoassays.
FormulationLyophilized from sterile PBS, PH 7.4
StorageStore at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.


Reference




    Validation Data


    Click to get more Data / Case study about the product.



    Target/Biomarker Information


    Equine CYSC, or Cystatin C, may appear modest in size, but its significance in the realm of equine health is monumental. This unassuming biomarker operates as a vigilant guardian, meticulously assessing the intricate machinery within a horse's body, specifically, the renal system.

    Produced by cells throughout a horse's body at a constant rate, Equine CYSC embarks on a journey that culminates in the evaluation of renal health. Its voyage begins within the glomeruli, the complex filtration units nestled within the horse's kidneys. Here, Equine CYSC is filtered from the blood, marking the initial step in the assessment of renal function.

    Following its passage through the glomeruli, Equine CYSC continues its odyssey through the renal tubules. Its fate is intricately tied to the efficiency of glomerular filtration. In healthy horses, the majority of CYSC is reabsorbed and subsequently catabolized by the tubules. This intricate process ensures that CYSC levels in the bloodstream remain relatively stable, mirroring the efficiency of glomerular filtration.

    The true strength of Equine CYSC lies in its sensitivity and specificity as a biomarker for renal health. Unlike traditional markers such as creatinine, which can be influenced by factors like muscle mass or diet, CYSC remains relatively immune to these variables. This precision makes CYSC an invaluable tool for the early detection of kidney disease in horses.

    Equine CYSC is not merely a biomarker; it is the herald of proactive healthcare. Its ability to detect subtle shifts in renal function, often before overt clinical symptoms manifest, makes it a powerful asset. Regular monitoring of CYSC levels can unveil renal issues in their infancy, allowing for timely intervention and an increased likelihood of successful treatment.



    About GDU


    GDU

    GDU helps global diagnostic partners in high quality of raw material discovery, development, and application. GDU believes in Protein&antibody Innovation for more reliable diagnostic solutions.